Log In
CQMS
Make a Donation
Log In
Donate
DONATE OR FUNDRAISE
Donate
Read Roland's story about participating in a prostate cancer trial
2026 Clinical Research Education Workshop (CREW) - Virtual attendance now available
Notice of AGM of the Trans Tasman Radiation Oncology Group .
First participant recruited for new lung cancer trial

TROG 96.06 – Melanoma (Phase II)

Completed
Skin

A Phase II Study of Radiation Therapy Following Nodal Surgery in Malignant Melanoma

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)
Prev Post

TROG 96.07 – Merkel Cell – Skin

Next Post

TROG 96.05 – Neuropathic Bone

Related Post

26 March, 2026

TROG welcomes new Board members and President-Elect

LATEST NEWS: 26 March 2026 We are delighted to

26 March, 2026

TROG’S 38th ASM puts focus on driving innovative trials

LATEST NEWS: 26 March 2026 TROG’s 2026 Annual Scientific